Staphylococcus aureus is an important bacterial pathogen that produces a range of Staphylococcal Enterotoxins (SEs) which cause gastroenteritis and superantigen activation of T cells, the mechanism of which is not well understood. The ability to rapidly detect and quantify SEs is very important in order to learn the causes of staphylococcal outbreaks and to stop similar outbreaks in the future. Enzyme-linked immunosorbent assays (ELISAs) have been developed for detection of several SEs. However, these immunological methods cannot distinguish between active and inactive toxin. It is known that interferon-gamma (IFN-γ) expressed in response to stimulation by SEs contributes significantly to the pathogenesis of S. aureus infection. Nonetheless, the cellular source of IFN-γ is still unclear and the contributions of the specific splenocyte types. In our effort to understand the immunologic response to Staphylococcal Enterotoxin A (SEA) exposure, we studied IFN-γ production in mouse splenocytes. We demonstrated that short term ex vivo exposure of splenocytes or primary naï ve CD4 + T-cells to biologically active SEA induces differential expression of IFN-γ mRNA in a time and dose dependent manner and the expression levels reflect the levels of IFN-γ secreted protein. Positive isolated CD4 + T-cells accounted for only 10% of IFN-γ production. We also demonstrate that expression of IFN-γ can be used for rapid quantitative analysis of active SEA with a detection limit of 1 ng/mL.
Introduction
Staphylococcus aureus is a leading bacterial pathogen of concern and a major cause of clinical infections and foodborne illnesses [1] . The pathogenicity of this bacterium is manifested through the production of enterotoxins (SEs), twenty-one of which have thus far been identified. The SEs target the gastrointestinal tract and also behave as superantigens in immune system response. These responses have been shown to be linked [2, 3] . Mutation studies demonstrate that the loss of superantigenic activity is correlated with a similar loss in enterotoxicity [4] . The ability to rapidly detect and quantify active SEs is very important in order to learn the causes of staphylococcal outbreaks and to stop similar outbreaks in the future. Thus it is essential to develop assays that distinguish the biologically active form of the toxin, which poses a threat, from the inactive form which poses no threat. SEA has been associated with three quarters of staphylococcal outbreaks and one such incident sickened 13,420 individuals in Japan when powdered skim milk was determined to be contaminated with SEA [5, 6] . In response to the need for improved methods to detect active SEs, we developed and reported a non-radioactive splenocyte cell-based assay which detects active SEA in food after 48 h [7] with greater sensitivity then alternate methods which rely upon in vivo response in monkey or kitten.
It has been shown that interferon-gamma (IFN-γ), a proinflammatory cytokine that keeps viruses from replicating and up-regulates the expressions of other disease-fighting agents, contributes significantly to the pathogenesis of S. aureus infection which causes toxic shock syndrome. However, the relative contribution of CD4 + T-cells subsets to IFN-γ response during SEA induced proliferation has remained largely undetermined. In addition, it in unknown whether CD4 + T-cells alone produce differential quantities of IFN-γ after SEA exposure. In this study we identify that only 10% of IFN-γ is produced by naï ve CD4 + T-cells and IFN-γ is differentially expressed in splenocyte and CD4 + T-cells after SEA exposure. The result shows that the levels of IFN-γ mRNA and its protein expression and secretion after SEA exposure can be used for detection and quantification of biologically active SEA.
Experimental Section

Chemicals and Reagents
SEA was obtained from Toxin Technology (Sarasota, FL, USA). CD4 + T-cell positive isolation kits were obtained from Invitrogen (Carlsbad, CA, USA). Mouse Cytometric Bead Array (BD Catalog No. 560485) for capture and detection of IFN-γ was obtained from BD Biosciences (San Diego, CA, USA).
Splenocyte Isolation
Spleens from C57BL/6 female mice were aseptically removed and disrupted using a syringe and needle in Russ-10 cell culture medium (made by combining 450 mL of RPMI 1640 medium without glutamine (Gibco/Life Technologies, Carlsbad, CA, USA), 50 mL fetal bovine serum (Hyclone, Logan, UT, USA), 5 mL 200 mM glutamine (Gibco), 5 mL antibiotic-antimycotic (Gibco; containing penicillin, streptomycin, and fungizone), 5 mL nonessential amino acid mix (Gibco), 5 mL sodium pyruvate (Gibco), and 0.25 mL of 100 mM beta mercaptoethanol (Sigma, St. Louis, MO, USA). Cells were centrifuged at 200× g at 4 °C for 10 min. Red blood cells were then lysed by adding red cell lysis buffer (0.15 M NH 4 Cl, 10 mM KHCO 3 , 0.1 mM Na 2 EDTA). Cells were again centrifuged and resuspended in Russ-10 medium, and viable cells were counted using trypan blue and a hemocytometer.
Positive Isolation of Murine CD4 + T-Cells
Using fresh splenocytes, murine CD4 + T-cells were isolated using a positive isolation method (Dynabeads Mouse CD4 L3T4 Isolation Kit, Invitrogen/Life Technologies, Carlsbad, CA, USA), according to the manufacturer's instructions. Briefly, splenocytes were resuspended in isolation buffer (PBS supplemented with 0.1% BSA and 2 mM EDTA) at a concentration of 1 × 10 7 /mL, and incubated with washed Dynabeads (25 L of Dynabeads per 10 7 cells) for 20 min on ice with gentle rotation.
After incubation, the cells and Dynabeads were placed on a magnet for 2 min. The supernatant was removed and the bead-bound cells were washed with isolation buffer three times. The bead-bound cells were resuspended in Russ-10 media (10 7 cells per 100 L of media) and DETACHaBEAD mouse CD4
was added (10 L per 10 7 cells) and incubated for 45 min with gentle rotation at room temperature.
The detached cells were washed three times and resuspended in media.
Quantitative RT-PCR Analysis
Quantitative RT-PCR (qRT-PCR) analysis for the early detection of SEA that induce IFN-γ was done as described previously [8] . The forward primer used for IFN-γ, was 5′-CATTGAAAGCCTAGAAAGTCTG-3′, and the reverse primer used was 5′-CTCATGAATGCATCCTTTTTCG-3′.
The housekeeping gene hypoxanthine-guanine phosphoribosyl transferase (Hprt) forward primer 5′-GTTGGATACAGGCCAGACTTTGTTG-3′ and the reverse primer used was 5′-GAGGGTAGGCTGGCCTATAGGCT-3′.
Cytokine IFN-γ ELISA
IFN-γ was measured in cell culture supernatants by capture ELISA Abs, purified standards, and protocols suggested by the manufacturer BD Biosciences Catalog No. 555138.
Statistical Analysis
Statistical analysis of ELISA data was performed using SigmaStat 3.5 for Windows (Systat Software, San Jose, CA, USA). Multiple comparisons of the spiked culture media were made. One-way analysis of variance (ANOVA) was used to compare control unspiked media with media that contained increasing concentrations of SEA. The experiments were repeated at least three times and results with p < 0.05 were considered statistically significant.
Flow Cytometry
IFN-γ in splenocyte and CD4
+ T-cells was quantified using a Mouse Cytometric Bead Array (BD Catalog No. 560485) for capture and detection of IFN-γ, using the method specified by the manufacturer (BD Biosciences). Data were collected using a modified FACS Vantage SE (BD Biosciences) having a Cobolt Calypso TM 491 nm (blue), 100 mW primary laser (Cobolt AB, Stockholm, Sweden) and a Cube TM 640 nm (red), 40 mW secondary laser (Coherent Inc., Santa Clara, CA, USA). Bead populations targeting IFN-γ, were discerned by fluorescence intensity in a channel excited by the red laser and selected using a 676/29 nm bandpass filter (Semrock, Rochester, NY, USA). Blue laser excited R-phycoerythrin (PE) fluorescence reported cytokine intensity and was quantified using a 585/42 nm bandpass filter. Data were initially analyzed using FlowJo software (TreeStar Inc., Ashland, OR, USA) and subsequently with SigmaPlot 11.0 software (Systat Software, San Jose, CA, USA) for statistical analysis and fit to standard data.
Results and Discussion
IFN-γ is Differentially Transcribed after SEA Exposure
Enterotoxins were shown to induce high levels of IFN-γ secretion and significantly contribute to the pathogenesis of S. aureus infection. In order to develop an assay for early detection of active SEA we examined if SEA is able to induce IFN-γ mRNA in dose dependent manner in splenocytes. We also 
IFN-γ Expression after Stimulation of Splenocytes or CD4 + T-Cells with SEA
The molecular data shows that IFN-γ expression is upregulated in dose dependent manner at the transcriptional level in CD4 
Detection of Biologically Active SEA by ELISA
Although our flow cytometry results were rapid and sensitive, using this analytical method requires expensive equipment and skilled personnel. To overcome this aspect, we used an ELISA test that measured the secreted IFN-γ protein produced from splenocytes and positive isolated CD4 
Conclusions/Outlook
The current methods to detect active SEA, associated with 75% of food borne staphylococcal outbreaks [9] , are an in vivo monkey or kitten bioassay [10, 11] . However, these procedures have low sensitivity and poor reproducibility. Enzyme-linked immunosorbent assays (ELISA) and mass spectrophotometry (MS) have been developed for detection of several SEs [11, 12] , but these immunological methods cannot distinguish between active and inactive forms of the toxin. Previously, we developed a sensitive assay that can detect and quantify active SEA. While this assay, which measures BrdU incorporation into cellular DNA, is very sensitive with good reproducibility, it requires 48 h incubation [7] . It was found that a subtype of mouse naï ve CD4 + T cells expresses MHC (major histocompatibility complex) class II molecules on their cell surface and these CD4 + T cells can perform the role of both antigen presenting cell and T cells. Thus, they are able to present SEA to themselves or neighboring CD4 + T cells via MHC class II. We showed that in the absence of nearly all other splenocyte cell types there was no decreased SEA induced proliferation of naï ve CD4 + T cells compared to proliferation levels of all splenocytes [13] . It has been shown that IFN-γ, which is expressed in response to stimulation by SEs, contributes to the pathogenesis of S. aureus infection. However, it is still unclear the cellular source of IFN-γ. CD4 + T cells are believed to be the primary cellular source of IFN-γ during SEA stimulation. Our results show that there was less induction of IFN-γ by SEA in naïve CD4 + T cells compared to splenocytes. After stimulation with SEA, CD4 + T-cells accounted for only 10% of total IFN-γ production compared to splenocytes. This result suggests that CD4 + T-cells were not the only source of IFN-γ production in splenocytes. It has previously been shown by [14] that in CD4 + T cell-deficient mice, IFN-gamma production was due to CD8 + T cells. It has been shown that neutrophils are a source of IFN-γ during acute Salmonella colitis [15] . Our results show that IFN-γ mRNA and secretion of IFN-γ protein are differentially expressed after exposure to SEA. The result suggests that induction of IFN-γ mRNA expression and protein production can be used for quantitative analysis of SEA. The result also suggests that the assay can distinguish between biologically active form of SEA, which poses a threat, and the inactive form which poses no threat.
Employed alone, the assay cannot distinguish SEA from other unknown toxins or elicitors of IFN-γ. Furthermore, as when analyzing complex matrices such as food, the induction of IFN-γ by SEA in food may require prior selective isolation of SEA from the food matrices and subsequent analysis to address the concern about the effect of the matrix and possible confounding elicitors. We have previously demonstrated that by concentrating the toxin from a large volume and disassociation of SEA using immunomagnetic beads, we were able to improve the specificity and sensitivity to detect 20 pg/mL of active SEA [7] .
Finally, while it is expected that a similar assay may be performed using human PBMCs, the use of splenocytes from mice is a more widely and practical method. The use of PBMCs from healthy human donors requires approval by an institutional review board and the need of a phlebotomist, both of which add complexity. Furthermore using PBMCs from human is not practical for a clinical method because unlike mice, human healthy donors are not always available.
